Sivik Global Healthcare LLC increased its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 33.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 120,000 shares of the medical equipment provider’s stock after purchasing an additional 30,000 shares during the period. Smith & Nephew SNATS accounts for 1.5% of Sivik Global Healthcare LLC’s portfolio, making the stock its 27th largest position. Sivik Global Healthcare LLC’s holdings in Smith & Nephew SNATS were worth $4,368,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in SNN. Bessemer Group Inc. lifted its holdings in shares of Smith & Nephew SNATS by 400.2% in the 3rd quarter. Bessemer Group Inc. now owns 2,781 shares of the medical equipment provider’s stock worth $102,000 after purchasing an additional 2,225 shares during the last quarter. Paloma Partners Management Co bought a new stake in Smith & Nephew SNATS during the 1st quarter valued at $200,000. Lbmc Investment Advisors LLC bought a new stake in Smith & Nephew SNATS during the 3rd quarter valued at $206,000. Greenleaf Trust bought a new stake in Smith & Nephew SNATS during the 2nd quarter valued at $207,000. Finally, Quantbot Technologies LP raised its stake in Smith & Nephew SNATS by 270.0% during the 2nd quarter. Quantbot Technologies LP now owns 7,277 shares of the medical equipment provider’s stock valued at $253,000 after acquiring an additional 5,310 shares in the last quarter. 6.39% of the stock is currently owned by institutional investors and hedge funds.

Shares of Smith & Nephew SNATS, Inc. (NYSE SNN) traded up $0.21 during trading on Thursday, reaching $35.79. The company’s stock had a trading volume of 416,100 shares, compared to its average volume of 501,076. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.08 and a current ratio of 2.18. Smith & Nephew SNATS, Inc. has a 52-week low of $27.26 and a 52-week high of $40.43.

The firm also recently announced a semiannual dividend, which was paid on Wednesday, November 1st. Shareholders of record on Friday, October 6th were paid a dividend of $0.246 per share. This represents a yield of 1.37%. The ex-dividend date of this dividend was Thursday, October 5th.

COPYRIGHT VIOLATION NOTICE: “Sivik Global Healthcare LLC Buys 30,000 Shares of Smith & Nephew SNATS, Inc. (SNN)” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/sivik-global-healthcare-llc-buys-30000-shares-of-smith-nephew-snats-inc-snn/1722011.html.

Several brokerages have weighed in on SNN. Zacks Investment Research downgraded Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Canaccord Genuity began coverage on Smith & Nephew SNATS in a research note on Wednesday, October 11th. They set a “buy” rating and a $42.00 target price on the stock. Finally, BidaskClub raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research note on Tuesday, August 1st. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $42.50.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.